Loading...
Ketanserin in essential hypertension: a double-blind, placebo-controlled study.
The antihypertensive effect of the selective serotonin antagonist ketanserin was examined in a double-blind, placebo-controlled, parallel group study in 20 patients with essential hypertension. After 7 weeks treatment with ketanserin (mean dose 71 mg/d) there was a significant fall of both systolic...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BMJ Group
1985
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2418322/ https://ncbi.nlm.nih.gov/pubmed/3161013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|